Updated Jul 16, 2026
Dulac Edward J III has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $248K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | NTLA | Intellia Therapeutics, Inc. | S — Open-market sale | 4.7K | $18.00 | $84K |
| 2026-03-03 | NTLA | Intellia Therapeutics, Inc. | A — Grant or award | 61.3K | $0.00 | |
| 2026-01-07 | NTLA | Intellia Therapeutics, Inc. | S — Open-market sale | 6.4K | $9.21 | $59K |
| 2025-07-23 | NTLA | Intellia Therapeutics, Inc. | S — Open-market sale | 7.5K | $14.02 | $105K |
Dulac Edward J III is a corporate insider — currently tracked as Insider of Intellia Therapeutics, Inc. (NTLA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($248K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dulac Edward J III profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.